You are here: University of Sydney / Faculty of Pharmacy / Academic Staff / Professor Ines Krass 

Professor Ines Krass

BPharm, Dip Hosp Pharm, Grad Dip Educ Studies (Health Ed), PhD
Professor in Pharmacy Practice

A15 - Pharmacy And Bank Building
The University of Sydney

Telephone +61 2 9351 3507
Fax +61 2 9351 4391

Biographical details

Ines Krass joined the Faculty of Pharmacy at the University of Sydney as a lecturer in 1993 and is now Professor in Pharmacy Practice. In 20 years in academia, she has built a strong national and international reputation in health services research in community pharmacy, as evidenced through her 126 refereed publications, visiting professorships, invitations to speak at national and international conferences, contributions to subject reviews and positions within international research organisations and journal editorial boards. Professor Krass has supervised 19 higher degree students to completion of their higher degree (12 PhDs, seven Master of Pharmacy/Clinical Pharmacy students) and is currently supervising six higher degree students.

Back to Top

Research interests

Professor Krass’ research focuses on health services research in community pharmacy. This involves the development, implementation and evaluation of chronic disease care models delivered by pharmacists for asthma and diabetes; screening and prevention of diabetes, CV disease, asthma and sleep disorders; and the validation of measures of pharmacist and consumer attitudes and behaviours. Over recent years she has been intensively involved in research on the development and implementation of disease state management programs (DSM) in community pharmacy for type 2 diabetes and asthma. She led a national research team which published the first Australian evidence supporting the role of the community pharmacist in caring for patients with diabetes. This research has directly informed the implementation of diabetes-related services in community pharmacy. Professor Krass also has a special research interest in measurement and validation of psychometric instruments. A series of instruments to assess the attitudes, knowledge, behaviours and satisfaction of both pharmacists and consumers have been developed and validated.

Back to Top

Selected grants

2012

  • Can we achieve better clinical and economic outcomes for chronic disease management in primary care asthma and hypertension?; Armour C, Bajorek B, Krass I, Hayes A, Roberts C; Heart Foundation of Australia/Grants-in-Aid.

2010

  • The increasing burden of stroke with ageing: using CARAT to optimise preventative treatment in the community; Bajorek B, Krass I, Hilmer S, Magin P; National Health and Medical Research Council/Project Grants.

2009

  • Leica DMI 6000B fully automated digital fluorescence microscope with camera and software; Krass I, Sukkar M; Clive & Vera Ramaciotti Foundation/Awards for Biomedical Research: Major Equipment.

2008

  • Asthma Pilot Program; Armour C, Saini B, Krass I, Bosnic-Anticevich S, Smith L; Department of Health and Ageing (Federal)/Asthma Management Program.
  • Role of pharmacists in sleep health - a screening, awarness and monitoring program; Saini B, Krass I; Pharmacy Guild of Australia/Investigator Initiated Grants (IIG).

2007

  • Diabetes Pilot Program; Krass I; Commonwealth Department of Health and Ageing/Research Grant.

2005

  • Professional ethics in Pharmacy.; Brien J, Chaar B, Krass I; Pharmacy Board of NSW/Education and Research Grant.
  • Goal setting in patient self-management of allergic rhinitis; Armour C, Saini B, Krass I, Bosnic-Anticevich S, Hammond S, Smith L; Schering-Plough Pty Ltd/BLO Project.

2004

  • Asthma self-management in the community: pharmacists facilitating empowerment of patient asthma self-management practices through collaboration; Armour C, Bosnic-Anticevich S, Krass I, Saini B; Pharmacy Guild of Australia/Research Grant.
  • Pharmacy Action Care Program; Armour C, Bosnic-Anticevich S, Krass I, Saini B, Smith L, Stewart K, Burton D, Lough S, Stewart P, Simpson M, Lough S; Pharmacy Guild of Australia/Research Grant.
  • A collaborative, interprofessional, evidence based approach to reducing coronary heart disease in rural areas; Emerson L, Benrimoj S, Krass I, Grant V, Emerson L; Pharmacy Guild of Australia/Invest Initiat Project.

2003

  • A community pharmacy based anticoalgulant management service; McLachlan A, Krass I, Chen T; Pharmacy Guild of Australia/Research Grant.
  • Pharmacy diabetes care program; Krass I, Armour C, Taylor S, Hughes J, Peterson M, Stewart K; Pharmacy Guild of Australia/Commissioned Projects.
  • Community pharmacy models for asthma managment in rural Australia; Armour C, Bosnic-Anticevich S, Krass I, Saini B, Taylor S; Pharmacy Guild of Australia/Research Grant.

2002

  • Pharmacy Astma Action Plan Program- Pharmacists addressing the issues ini the community; Krass I, Saini B, Bosnic-Anticevich S, Armour C; NSW Department of Health/Research Grant.
  • An integrated model for disease state management (DMS) in diabetes: collaboration of the community pharmacist and GP in continuity of care; Krass I, Armour C, Taylor S; Pharmacy Guild of Australia/Research Grant.
  • Managing Asthma in Rural Communities; Armour C, Saini B, Bosnic-Anticevich S, Krass I, Taylor S, Dalton A, Hulme F; Commonwealth Department of Health and Ageing/Research Grant.

2000

  • SugarCare: Development, implementation and evaluation of best practice guidelines for a disease management program and professional remuneration strategy for ..; Armour C, Krass I; Commonwealth Department of Health and Aged Care/Other Program and Contract Research.
  • Development, implementation and evaluation of a health promotion and screening service in community pharmacy; Krass I, Chen T, Smith D; Commonwealth Department of Health and Aged Care/Guild/Government Agreement.
  • Optimising the use of antithrombotic therapy in elderly patients with atrial fibrillation; Krass I; Commonwealth Department of Health and Aged Care/Quality Use of Medicines Evaluation Program.
Back to Top

Selected publications

Download citations: PDF RTF Endnote

Edited Books

  • Krass, I., Aslani, P. (2002). The 12th International Social Pharmacy Workshop. Australia: Faculty of Pharmacy, University of Sydney.

Book Chapters

  • Armour, C., Chaar, B., Murray, M., Ambler, G., Krass, I. (2012). Current therapies and pharmacy programs for obesity and diabetes. In Louise A. Baur, Stephen M. Twigg, Roger S.Magnusson (Eds.), A Modern Epidemic: Expert Perspectives on Obesity and Diabetes, (pp. 315-338). Sydney, Australia: Sydney University Press.
  • Krass, I., Bell, J. (2011). An International Perspective. In Janet Krska (Eds.), Pharmacy in Public Health, (pp. 67-81). London: Pharmaceutical Press.
  • Krass, I., Armour, C. (2011). Preventing Disease: Screening in the Pharmacy. In Janet Krska (Eds.), Pharmacy in Public Health, (pp. 221-243). London: Pharmaceutical Press.
  • Armour, C., Saini, B., Bosnic-Anticevich, S., Krass, I. (2005). Role of pharmacists in asthma monitoring. In Peter G. Gibson (Eds.), Monitoring Asthma: Lung Biology in Health and Disease Series, Volume 207, (pp. 145-158). United States: Taylor and Francis.

Journals

  • Mansoor, S., Krass, I., Aslani, P. (2013). Multi Professional Interventions to Improve Adherence to Cardiovascular Medications. Journal of Cardiovascular Pharmacology and Therapeutics, 18(1), 19-30.
  • Eissa, A., Krass, I., Bajorek, B. (2012). Barriers to the utilization of thrombolysis for acute ischaemic stroke. Journal Of Clinical Pharmacy And Therapeutics, 37(4), 399-409.
  • Giam, J., McLachlan, A., Krass, I. (2012). Characterizing specialized compounding in community pharmacies. Research in Social and Administrative Pharmacy, 8(3), 240-252.
  • Van, C., Costa, D., Abbott, P., Mitchell, B., Krass, I. (2012). Community pharmacist attitudes towards collaboration with general practitioners: development and validation of a measure and a model. BMC Health Services Research, 12, 1-10.
  • Krass, I., Walker, A., Watts, G. (2012). Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist? International Journal of Clinical Pharmacy, 34(4), 501-505.
  • Van, C., Costa, D., Mitchell, B., Abbott, P., Krass, I. (2012). Development and initial validation of the Pharmacist Frequency of Interprofessional Collaboration Instrument (FICI-P) in primary care. Research in Social and Administrative Pharmacy, 8, 397-407.
  • Van, C., Costa, D., Mitchell, B., Abbott, P., Krass, I. (2012). Development and validation of the GP frequency of interprofessional collaboration instrument (FICI-GP) in primary care. Journal of Interprofessional Care, 26(4), 297-304.
  • Bajorek, B., Masood, N., Krass, I. (2012). Development of a Computerised Antithrombotic Risk Assessment Tool (CARAT) to optimise therapy in older persons with atrial fibrillation. Australasian Journal on Ageing, 31(2), 102-109.
  • Balisa-Rocha, B., Guimaraes, V., Mesquita, A., Aguiar, P., Krass, I., Pereira de Lyra Jr., D. (2012). Enhancing Health Care for Type 2 diabetes in Northern Brazil: A Pilot Study of Pharmaceutical Care in Community Pharmacy. African Journal of Pharmacy and Pharmacology, 6(35), 2584-2591.
  • Bassett-Clarke, D., Krass, I., Bajorek, B. (2012). Ethnic differences of medicines-taking in older adults: a cross cultural study in New Zealand. The International Journal of Pharmacy Practice, 20(2), 90-98.
  • Emmerton, L., Smith, L., LeMay, K., Krass, I., Saini, B., Bosnic-Anticevich, S., Reddel, H., Burton, D., Stewart, K., Armour, C. (2012). Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Services Research, 12(1), 1-10.
  • van Dalem, J., Krass, I., Aslani, P. (2012). Interventions promoting adherence to cardiovascular medicines. International Journal of Clinical Pharmacy, 34(2), 295-311.
  • Eissa, A., Krass, I., Bajorek, B. (2012). Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). Journal Of Clinical Pharmacy And Therapeutics, 37(6), 620-629.
  • Lowres, N., Freedman, S., Redfern, J., McLachlan, A., Krass, I., Bennett, A., Briffa, T., Bauman, A., Neubeck, A. (2012). Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke in an ambulant population aged >65 years (SEARCH-AF stroke prevention study): a cross-sectional study protocol. BMJ Open, 2(3), 1-6.
  • Aslani, P., Rose, G., Chen, T., Whitehead, P., Krass, I. (2011). A community pharmacist delivered adherence support service for dyslipidaemia. European Journal of Public Health, 21(5), 567-572.
  • Saini, B., LeMay, K., Emmerton, L., Krass, I., Smith, L., Bosnic-Anticevich, S., Stewart, K., Burton, D., Armour, C. (2011). Asthma disease management-Australian pharmacists' interventions improve patients' asthma knowledge and this is sustained. Patient Education and Counseling, 83(3), 295-302.
  • Kanjanarach, T., Krass, I., Cumming, R. (2011). Australian community pharmacists' practice in complementary medicines: A structural equation modeling approach. Patient Education and Counseling, 83(3), 352-359.
  • Giam, J., McLachlan, A., Krass, I. (2011). Community pharmacy compounding-impact on professional status. International Journal of Clinical Pharmacy, 33(2), 177-182.
  • Krass, I., Hebing, R., Mitchell, B., Hughes, J., Peterson, G., Song, Y., Stewart, K., Armour, C. (2011). Diabetes management in an Australian primary care population. Journal Of Clinical Pharmacy And Therapeutics, 36(6), 664-672.
  • Krass, I., Mitchell, B., Song, Y., Stewart, K., Peterson, G., Hughes, J., Smith, L., White, L., Armour, C. (2011). Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes. Diabetic Medicine, 28(8), 987-993.
  • Mitchell, B., Armour, C., Lee, M., Song, Y., Stewart, K., Peterson, G., Hughes, J., Smith, L., Krass, I. (2011). Diabetes Medication Assistance Service: The pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia. Patient Education and Counseling, 83(3), 288-294.
  • Watts, G., Sullivan, D., Poplawski, N., van Bockxmeer, F., Hamilton-Craig, I., Clifton, P., O'Brien, R., Bishop, W., George, P., Barter, P., Freeman, L., Krass, I., Trent, R., et al (2011). Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements, 12, 221-263.
  • Van, C., Mitchell, B., Krass, I. (2011). General practitioner-pharmacist interactions in professional pharmacy services. Journal of Interprofessional Care, 25(5), 366-372.
  • Saini, B., Krass, I., Smith, L., Bosnic-Anticevich, S., Armour, C. (2011). Role of community pharmacists in asthma - Australian research highlighting pathways for future primary care models. The Australasian Medical Journal, 4(4), 190-200.
  • Fuller, J., Wong, K., Krass, I., Grunstein, R., Saini, B. (2011). Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Patient Education and Counseling, 83(3), 325-335.
  • Armour, C., LeMay, K., Saini, B., Reddel, H., Bosnic-Anticevich, S., Smith, L., Burton, D., Song, Y., Alles, M., Stewart, K., Krass, I., et al (2011). Using the Community Pharmacy to Identify Patients at Risk of Poor Asthma Control and Factors which Contribute to this Poor Control. Journal of Asthma, 48(9), 914-922.
  • Aslani, P., Rose, G., Chen, T., Whitehead, P., Krass, I. (2010). A community pharmacist delivered adherence support service for dyslipidaemia. European Journal of Public Health, 21(5), 567-572.
  • Livingston, C., Krass, I., Li, Q. (2010). Factors Predicting the Recommendations of General Practitioners on Herbal Therapies and Dietary Supplements to Patients. Journal of Complementary and Integrative Medicine, 7(1), 1-14.
  • Um, I., Armour, C., Krass, I., Gill, T., Chaar, B. (2010). Managing obesity in pharmacy: the Australian experience. Pharmacy World and Science, , 1-10.
  • Puspitasari, H., Aslani, P., Krass, I. (2010). Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies. International Journal of Pharmacy Practice, 18(4), 202-208.
  • Smith, L., Krass, I., Sainsbury, E., Rose, G. (2010). Pharmacy students' approaches to learning in undergraduate and graduate entry programs. American Journal of Pharmaceutical Education, 74(6), 1-6.
  • Giam, J., McLachlan, A., Krass, I. (2010). Specialized compounding in community pharmacies: Organizational perspective. Journal of the American Pharmacists Association, 50, 354-361.
  • Puspitasari, H., Aslani, P., Krass, I. (2009). A review of counseling practices on prescription medicines in community pharmacies. Research in Social and Administrative Pharmacy, 5(3), 197-210.
  • Aslani, P., Krass, I. (2009). Adherence: a review of education, research, practice and policy in Australia. Pharmacy Practice, 7(1), 1-10.
  • Bajorek, B., Ogle, S., Duguid, M., Shenfield, G., Krass, I. (2009). Balancing risk versus benefit: the elderly patient's perspective on warfarin therapy. Pharmacy Practice, 7(2), 113-123.
  • Ryan, G., Hanrahan, J., Krass, I., Sainsbury, E., Smith, L. (2009). Best Practices Assessment to Guide Curricular Change in a Bachelor of Pharmacy Program. American Journal of Pharmaceutical Education, 73(1), 1-8.
  • VanRoozendaal Bob, B., Krass, I. (2009). Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes. Pharmacy World and Science, 31(5), 580-595.
  • Krass, I., Mitchell, B., Armour, C. (2009). Early experiences in the implementation of the Diabetes Pilot Program Stage 1. Australian Journal of Pharmacy, 90(1070), 69-71.
  • Puspitasari, H., Aslani, P., Krass, I. (2009). How do Australian metropolitan and rural pharmacists counsel consumers with prescriptions? Pharmacy World and Science, 31(3), 394-405.
  • Taylor, S., Hourihan, F., Krass, I., Armour, C. (2009). Measuring consumer preference for models of diabetes care delivered by pharmacists. Pharmacy Practice, 7(4), 195-204.
  • Krass, I., Delaney, C., Glaubitz, S., Kanjanarach, T. (2009). Measuring patient satisfaction with diabetes disease state management services in community pharmacy. Research in Social and Administrative Pharmacy, 5(1), 31-39.
  • Chaar, B., Brien, J., Krass, I. (2009). Professional ethics in pharmacy practice: developing a psychometric measure of moral reasoning. Pharmacy World and Science, 31(4), 439-449.
  • Tran, A., Fuller, J., Wong, K., Krass, I., Grunstein, R., Saini, B. (2009). The development of a sleep disorder screening program in Australian community pharmacies. Pharmacy World and Science, 31(4), 473-480.
  • Ryan, G., Bonanno, H., Krass, I., Scouller, K., Smith, L. (2009). Undergraduate and Postgraduate Pharmacy Students Perceptions of Plagiarism and Academic Honesty. American Journal of Pharmaceutical Education, 73(6), 1-8.
  • Saini, B., Filipovska, J., Bosnic-Anticevich, S., Taylor, S., Krass, I., Armour, C. (2008). An evaluation of a community pharmacy-based rural asthma management service. Australian Journal of Rural Health, 16(2), 100-108.
  • Armour, C., Smith, L., Krass, I. (2008). Community pharmacy, disease state management, and adherence to medication - A review. Disease Management and Health Outcomes, 16(4), 245-254.
  • O'Connor, J., Seeto, C., Saini, B., Bosnic-Anticevich, S., Krass, I., Armour, C., Smith, L. (2008). Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Education and Counseling, 70(1), 111-117.
  • Scouller, K., Bonanno, H., Smith, L., Krass, I. (2008). Student experience and tertiary expectations: factors predicting academic literacy amongst first-year pharmacy students. Studies in Higher Education, 33(2), 167-178.
  • Raynor, D., Svarstad, B., Knapp, P., Aslani, P., Rogers, M., Koo, M., Krass, I., Silcock, J. (2007). Consumer medication information in the United States, Europe, and Australia: a comparative evaluation. Journal of the American Pharmacists Association, 47(6), 717-724.
  • Gordois, A., Armour, C., Brillant, M., Bosnic-Anticevich, S., Burton, D., Emmerton, L., Krass, I., Saini, B., Smith, L., Stewart, K. (2007). Cost-effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes, 15(6), 387-396.
  • Aslani, P., Benrimoj, S., Krass, I. (2007). Development and evaluation of a training program to foster the use of written drug information in community pharmacies. Part 2: evaluation. Pharmacy Education, 7(2), 141-149.
  • Koo, M., Krass, I., Aslani, P. (2007). Evaluation of written medicine information: validation of the Consumer Information Rating Form. The Annals of Pharmacotherapy, 41(6), 951-956.
  • Van, C., Krass, I., Mitchell, B. (2007). General practitioner perceptions of extended pharmacy services and modes of collaboration with pharmacists. Journal of Pharmacy Practice and Research, 37(3), 182-186.
  • Bajorek, B., Ogle, S., Duguid, M., Shenfield, G., Krass, I. (2007). Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers. Medical Journal of Australia, 186(4), 175-180.
  • Armour, C., Smith-Brillant, M., Krass, I. (2007). Pharmacists' views on involvement in pharmacy practice research: Strategies for facilitating participation. Pharmacy Practice, 5(2), 59-66.
  • Armour, C., Brillant, M., Krass, I. (2007). Pharmacists' views on involvement in pharmacy practice research: Strategies for facilitating participation. Pharmacy Practice, 5(2), 59-66.
  • Armour, C., Bosnic-Anticevich, S., Smith-Brillant, M., Burton, D., Emmerton, L., Krass, I., Saini, B., Smith, L., Stewart, K. (2007). Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax: an international journal of respiratory medicine, 62(6), 496-502.
  • Smith, L., Saini, B., Krass, I., Chen, T., Bosnic-Anticevich, S., Sainsbury, E. (2007). Pharmacy students' approaches to learning in an Australian university. American Journal of Pharmaceutical Education, 71(6), 120-1-120-8.
  • Lee, D., Armour, C., Krass, I. (2007). The development and evaluation of written medicines information for type 2 diabetes. Health Education Research, 22(6), 918-930.
  • Krass, I., Armour, C., Mitchell, B., Smith-Brillant, M., Dienaar, R., Hughes, J., Lau, P., Peterson, G., Stewart, K., Taylor, S., et al (2007). The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Medicine, 24(6), 677-683.
  • Smith, L., Bosnic-Anticevich, S., Mitchell, B., Saini, B., Krass, I., Armour, C. (2007). Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Social Science and Medicine, 64(7), 1501-1511.
  • Armour, C., Krass, I., Hulme, F., Dalton, A., Saini, B., Filipovska, J., Bosnic-Anticevich, S., Taylor, S. (2006). ABS71: An evaluation of a community pharmacy based rural asthma management service. Primary Care Respiratory Journal, 15(3), 205-205.
  • Saini, B., Smith, L., Armour, C., Krass, I. (2006). An educational intervention to train community pharmacists in providing specialized asthma care. American Journal of Pharmaceutical Education, 70(5), Article 118-1-118-10.
  • Aslani, P., Benrimoj, S., Krass, I. (2006). Development and Evaluation of a training program to foster the use of written drug information in community pharmacies - Part 1 - Development. Pharmacy Education, 6(1), 41-52.
  • Koo, M., Krass, I., Aslani, P. (2006). Enhancing patient education about medicines: factors influencing reading and seeking of written medicine information. Health expectations : an international journal of public participation in health care and health policy, 9(2), 174-187.
  • Kanjanarach, T., Krass, I., Cumming, R. (2006). Exploratory study of factors influencing practice of pharmacists in Australia and Thailand with respect to dietary supplements and complementary medicines. International Journal of Pharmacy Practice, 14(2), 123-128.
  • Krass, I., Mitchell, B., Clarke, P., Brillant, M., Dienaar, R., Hughes, J., Lau, P., Peterson, G., Stewart, K., Taylor, S., Armour, C., et al (2006). Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Research and Clinical Practice, 75(3), 339-347.
  • Krass, I., Taylor, S., McInman, A., Armour, C. (2006). The pharmacist's role in continuity of care in type 2 diabetes: An evaluation of a model. Journal of Pharmacy Technology, 22(1), 3-8.
  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2006). Warfarin use in the elderly: the nurses' perspective. Australian Journal of Advanced Nursing, 23(3), 19-25.
  • Taylor, S., Milanova, T., Hourihan, F., Krass, I., Coleman, C., Armour, C. (2005). A cost-effectiveness analysis of a community pharmacist-initiated disease state management service for type 2 diabetes mellitus. International Journal of Pharmacy Practice, 13(1), 33-40.
  • Koo, M., Krass, I., Aslani, P. (2005). Consumer use of Consumer Medicine Information. Journal of Pharmacy Practice and Research, 35(2), 94-98.
  • Krass, I., Taylor, S., Smith, C., Armour, C. (2005). Impact on Medication Use and Adherence of Australian Pharmacists' Diabetes Care Services. Journal of the American Pharmacists Association, 45(1), 33-40.
  • Kritikos, V., Saini, B., Bosnic-Anticevich, S., Krass, I., Shah, S., Taylor, S., Armour, C. (2005). Innovative asthma health promotion by Rural Community Pharmacists: a feasibility study. Health Promotion Journal of Australia, 16(1), 69-73.
  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2005). Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A Pharmacist-Led Multidisciplinary Intervention. Journal of the American Geriatrics Society, 53(11), 1912-1920.
  • Koo, M., Krass, I., Aslani, P. (2005). Patient characteristics influencing evaluation of medicine information: Lessons for patient education. The Annals of Pharmacotherapy, 39(9), 1434-1440.
  • Chaar, B., Brien, J., Krass, I. (2005). Professional ethics in pharmacy: the Australian experience. International Journal of Pharmacy Practice, 13, 195-204.
  • Lee, D., Armour, C., Krass, I. (2005). The development and evaluation of written medicine information (WMI) for patients with type 2 diabetes. Australian Journal of Pharmacy, 86(1024), 524-528.
  • Bennett, A., Krass, I., Brien, J. (2005). The future burden of cardiovascular disease: what can pharmacists do? Australian Journal of Pharmacy, 86(1020), 166-169.
  • Kritikos, V., Krass, I., Chan, H., Bosnic-Anticevich, S. (2005). The Validity and Reliability of Two Asthma Knowledge Questionnaires. Journal of Asthma, 42(9), 795-801.
  • Aslani, P., Rose, G., Owen, L., Krass, I., Chen, T., Whitehead, P. (2004). A Therapeutics Outcome Monitoring Service For Hyperlipidaemia. Australian Journal of Pharmacy, 85(1016), 870-873.
  • Saini, B., Krass, I., Armour, C. (2004). Development, Implementation And Evaluation Of A Community Pharmacy-Based Asthma Care Model. The Annals of Pharmacotherapy, 38(11), 1954-1960.
  • Saini, B., Krass, I., Armour, C. (2004). Development, Implementation, and Evaluation of a Community Pharmacy-Based Asthma Care Model. The Annals of Pharmacotherapy, 38(11), 1954-1960.
  • Armour, C., Taylor, S., Hourihan, F., Smith, C., Krass, I. (2004). Implementation And Evaluation Of Australian Pharmacists' Diabetes Care Services. Journal of the American Pharmacists Association, 44(4), 455-466.
  • Bajorek, B., Ogle, S., Krass, I., Duguid, M., Shenfield, G. (2003). Atrial Fibrillation in the Elderly: Management Issues. Indian Journal of Gerontology, 17(3 & 4), 244-272.
  • Koo, M., Krass, I., Aslani, P. (2003). Factors influencing consumer use of written drug information. The Annals of Pharmacotherapy, 37(2), 259-267.
  • Krass, I., Hourihan, F., Chen, T. (2003). Health promotion and screening for cardiovascular risk factors in NSW: a community pharmacy model. Health Promotion Journal of Australia, 14(2), 101-107.
  • Rossing, C., Holme Hansen, E., Krass, I., Traulsen, J. (2003). Pharmaceutical care in denmark: perceived importance of medicine-related problems and participation in postgraduate training. Pharmacy World and Science, 25(2), 73-78.
  • Kritikos, V., Watt, H., Krass, I., Sainsbury, E., Bosnic-Anticevich, S. (2003). Pharmacy students' perceptions of their profession relative to other health care professions. International Journal of Pharmacy Practice, 11(2), 121-129.
  • Chaar, B., Brien, J., Krass, I. (2003). Professional ethics in pharmacy. Australian Journal of Pharmacy, 84, 856-859.
  • Hourihan, F., Krass, I., Chen, T. (2003). Rural Community Pharmacy: A Feasible Site for a Health Promotion and Screening Service for Cardiovascular Risk Factors. Australian Journal of Rural Health, 11(1), 28-35.
  • Rossing, C., Hansen, E., Krass, I. (2003). The provision of pharmaceutical care in Denmark: a cross-sectional survey. Journal Of Clinical Pharmacy And Therapeutics, 28(4), 311-318.
  • Krass, I., Bajorek, B. (2002). "The pill" is now into its third generation. Retail Pharmacy, , 28-29.
  • Aslani, P., Bosnic-Anticevich, S., Sainsbury, E., Koo, M., Roberts, A., Krass, I. (2002). A report of the Teachers' workshop held in Sydney, Australia, 2002. Pharmacy Education, , 213-219.
  • Krass, I., Bajorek, B. (2002). An update on osteoporosis. Retail Pharmacy, , 35-36.
  • Rossing, C., Hansen, E., Krass, I. (2002). Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. Journal of Social and Administrative Pharmacy, 19(2), 55-64.
  • Krass, I. (2002). Change in pharmacy toward patient care or business. Journal of Social and Administrative Pharmacy, , 202-202.
  • Krass, I., Bajorek, B. (2002). Cholesterol and coronary heart disease. Retail Pharmacy, , 20-20.
  • Koo, M., Krass, I., Aslani, P. (2002). Consumer opinions on medicines information and factors affecting its use - an Australian experience. International Journal of Pharmacy Practice, 10, 107-114.
  • Saini, B., Jogia, R., Krass, I., Armour, C. (2002). Evaluation of a practice-based research design using an asthma care model. International Journal of Pharmacy Practice, 10, 177-184.
  • Krass, I., Bajorek, B. (2002). Gout comes under attack. Retail Pharmacy, , 28-29.
  • Krass, I., Bajorek, B. (2002). Have trouble explaining INR to warfarin patients. Retail Pharmacy, , 29-30.
  • Krass, I. (2002). Hyperlipidaemia. Australian Pharmacist, , 190-194.
  • Masood, N., Armour, C., Krass, I. (2002). Identifying potential medication related interventions in type 2 diabetes: a mechanism for enhanced community pharmacy services. Journal of Social and Administrative Pharmacy, 19(5), 170-179.
  • Krass, I., Bajorek, B. (2002). Paying attention to AD/HD. Retail Pharmacy, , 24-25.
  • Smith, L., Krass, I. (2002). Responding to changes in pharmacy practice. Synergy, , 9-10.
  • Krass, I., Bajorek, B. (2002). Seize the knowledge on new anticonvulsants. Retail Pharmacy, , 28-29.
  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2002). The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation. Australasian Journal on Ageing, 21(1), 36-41.
  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2002). The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation. Australasian Journal on Ageing, 21(1), 36-41.
  • Krass, I., Bajorek, B. (2002). To be or not to be ulcer-free? that is the NSAID question. Retail Pharmacy, , 19-20.
  • Krass, I., Svarstad, B., Bultman, D. (2002). Using alternative methodologies for evaluating patient medication leaflets. Patient Education and Counseling, 47(1), 29-35.
  • Krass, I., Bajorek, B. (2002). What was new in medicines for 2002. Retail Pharmacy, , 35-36.
  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2001). A survey of long-term antiarrhythmic therapy in elderly patients with atrial fibrillation. Australian Journal of Hospital Pharmacy, 31(2), 93-97.
  • Chen, T., Crampton, M., Krass, I., Benrimoj, S. (2001). Collaboration between community pharmacists and GPs - impact on interprofessional communication. Journal of Social and Administrative Pharmacy, 18(3), 83-90.
  • Teh, R., Chen, T., Krass, I. (2001). Consumer perspectives of pharmacist-delivered health information and screening services. International Journal of Pharmacy Practice, 9, 261-267.
  • Saini, B., Krass, I., Armour, C. (2001). Specialisation in asthma: current practice and future roles - a qualitative study of practising community pharmacists. Journal of Social and Administrative Pharmacy, 18(5), 169-177.
  • Jones, J., Krass, I., Holder, G., Robinson, R. (2000). Selecting Pharmacy students with appropriate communication skills. American Journal of Pharmaceutical Education, 64, 68-73.
  • Holder, G., Jones, J., Robinson, R., Krass, I. (1999). Academic Literacy Skills and Progression Rates amongst Pharmacy Students. Higher Education Research and Development, 18(1), 19-30.

Conferences

  • Ahmed, R., Aslani, P., Krass, I. (2012). Community pharmacists' awareness of secondary prevention of cardiovascular disease: a preliminary study. Joint ASCEPT-APSA 2012 Conference: Medication Safety, Australia.
  • Mansoor, S., Krass, I., Aslani, P. (2012). Strategies used to support patients' adherence to medication: a national survey of community pharmacists. Joint ASCEPT-APSA 2012 Conference: Medication Safety, Australia.
  • Aslani, P., Mansoor, S., Krass, I. (2011). The provision of an adherence support service by community pharacists. Australasian Pharmaceutical Science Association (2011), Unkown.
  • Hamrosi, K., Aslani, P., Krass, I., Raynor, D. (2010). Consumer medicine information (CMI) with benefits: are they what consumers want?. Australasian Pharmaceutical Science Association Annual Conference (2010). Australasian Pharmaceutical Science Association.
  • Aslani, P., Krass, I., Bajorek, B., Thistlethwaite, J., Bunker, J., Tofler, G. (2009). Exploring the barriers to achieving quality use of medicines in cardiovascular health. Australasian Pharmaceutical Science Association (APSA) Annual Conference (2009) Aus-CRS Symposium, Mount Waverley, Melbourne, Australia: Australasian Pharmaceutical Science Association.
  • Puspitasari, H., Aslani, P., Krass, I. (2008). Consumers’ experiences of medicine information in community pharmacies. 15th International Social Pharmacy Workshop.
  • Puspitasari, H., Aslani, P., Krass, I. (2008). Provision of prescription medicines information by community pharmacists: A consumer and pharmacist perspective. Biennial Faculties of Health Research Conference: From Cell to Society 6, Australia: Faculty of Health Science, The University of Sydney.
  • Burton, D., Simpson, M., Wettenhall, J., Armour, C., Bosnic-Anticevich, S., Saini, B., Krass, I., Smith, L., Smith, L., Smith-Brillant, M., et al (2006). ACCEPTABILITY AND UTILITY OF SPIROMETRY MEASUREMENT IN THE PHARMACY ASTHMA CARE PROGRAM. 2006 Annual Scientific Meetings, The Thoracic Society of Australia and New Zealand & The Australian and New Zealand Society of Respiratory Science, Western Australia: Asian Pacific Society of Respirology.
  • Armour, C., Bosnic-Anticevich, S., Smith-Brillant, M., Burton, D., Emmerton, L., Gordois, A., Krass, I., Saini, B., Smith, L., Stewart, K. (2006). Asthma service delivered in community pharmacy provides positive clinical and humanistic outcomes and is cost-effective. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Chaar, B., Brien, J., Krass, I. (2006). Developing an instrument for measuring moral reasoning and professional ethics in pharmacy.
  • Lee, D., Armour, C., Krass, I. (2006). Development and evaluation of a diabetes medicines knowledge test (DMKT). 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Saini, B., Smith, L., Armour, C., Krass, I. (2006). Development and evaluation of an educational intervention to facilitate community pharmacists to provide specialised asthma care. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Lee, D., Armour, C., Krass, I. (2006). Development and randomised controlled evaluation of written medicines information (WMI) for type 2 diabetes. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Smith, L., Armour, C., Mitchell, B., Saini, B., Krass, I., Bosnic-Anticevich, S. (2006). Pharmacists facilitating patient self-management practices: an Australian community pharmacy asthma self-management programme. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Armour, C., Bosnic-Anticevich, S., Saini, B., Krass, I., Smith, L., Smith-Brillant, M., Burton, D., Simpson, M., Wettenhall, J., Emmerton, L., et al (2006). PHARMACISTS IMPROVING HEALTH CARE FOR ASTHMA. 2006 Annual Scientific Meetings, The Thoracic Society of Australia and New Zealand & The Australian and New Zealand Society of Respiratory Science, Western Australia: Asian Pacific Society of Respirology.
  • Armour, C., Benrimoj, S., Smith-Brillant, M., Gilbert, A., Howarth, H., Krass, I., Lau, P., McNamara, K., Peterson, G., Saini, B. (2006). The community pharmacy research support centre: an Australian consortium developing community pharmacy practice research. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Chaar, B., Brien, J., Krass, I. (2006). The role of moral reasoning in the processes of decision making and professional ethics in the Quality Use of Medicines (QUM) and pharmacy. National Medicines Symposium 2006, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Bosnic-Anticevich, S., Krass, I., Saini, B., Armour, C., Shah, S. (2002). Comparison of two methods of training of undergraduate students in asthma, knowledge, confidence and skills.
  • Koo, M., Krass, I., Aslani, P. (2002). Consumer medicines information: What do consumers do with them?. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Koo, M., Krass, I., Aslani, P. (2002). Development of a tool to measure factors affecting the use of written information by consumers. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Saini, B., Krass, I., Armour, C. (2002). Improvement in asthma management through a specialty pharmacy asthma care model. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Krass, I., Taylor, S., Armour, C., Stephenson,, S., Thusi, I., Hourihan, F. (2002). Increasing adherence to dedications through delivery of a disease state management service for Type 2 diabetes in community pharmacies. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Armour, C., Taylor, S., Smith, C., Krass, I., Hourihan, F. (2002). Pharmacists improve clinical outcomes for diabetes using a disease state management approach. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Bosnic-Anticevich, S., Saini, B., Krass, I., Armour, C. (2002). Pharmacy action plan program - pharmacists addressing issues in the community. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Bajorek, B., Krass, I. (2002). Warfarin use in elderly patients with atrial fibrillation: the pharmacy perspective. Australasian Pharmaceutical Scinece Association Conference, Sydney: Faculty of Pharmacy, University of Sydney.
  • Hourihan, F., Krass, I., Chen, T., Coper,, L. (2001). Consumer evaluation of a pharmacy based health promotion and screening service in rural NSW.
  • Smith, L., Krass, I. (2001). Responding to changes in Pharmacy practice: A collaboration between Nursing and Pharmacy in developing social Pharmacy curriculum. College of Health Sciences Ed-Health 2001, uk: World Scientific Publishing.

2013

  • Mansoor, S., Krass, I., Aslani, P. (2013). Multi Professional Interventions to Improve Adherence to Cardiovascular Medications. Journal of Cardiovascular Pharmacology and Therapeutics, 18(1), 19-30.

2012

  • Eissa, A., Krass, I., Bajorek, B. (2012). Barriers to the utilization of thrombolysis for acute ischaemic stroke. Journal Of Clinical Pharmacy And Therapeutics, 37(4), 399-409.
  • Giam, J., McLachlan, A., Krass, I. (2012). Characterizing specialized compounding in community pharmacies. Research in Social and Administrative Pharmacy, 8(3), 240-252.
  • Van, C., Costa, D., Abbott, P., Mitchell, B., Krass, I. (2012). Community pharmacist attitudes towards collaboration with general practitioners: development and validation of a measure and a model. BMC Health Services Research, 12, 1-10.
  • Ahmed, R., Aslani, P., Krass, I. (2012). Community pharmacists' awareness of secondary prevention of cardiovascular disease: a preliminary study. Joint ASCEPT-APSA 2012 Conference: Medication Safety, Australia.
  • Armour, C., Chaar, B., Murray, M., Ambler, G., Krass, I. (2012). Current therapies and pharmacy programs for obesity and diabetes. In Louise A. Baur, Stephen M. Twigg, Roger S.Magnusson (Eds.), A Modern Epidemic: Expert Perspectives on Obesity and Diabetes, (pp. 315-338). Sydney, Australia: Sydney University Press.
  • Krass, I., Walker, A., Watts, G. (2012). Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist? International Journal of Clinical Pharmacy, 34(4), 501-505.
  • Van, C., Costa, D., Mitchell, B., Abbott, P., Krass, I. (2012). Development and initial validation of the Pharmacist Frequency of Interprofessional Collaboration Instrument (FICI-P) in primary care. Research in Social and Administrative Pharmacy, 8, 397-407.
  • Van, C., Costa, D., Mitchell, B., Abbott, P., Krass, I. (2012). Development and validation of the GP frequency of interprofessional collaboration instrument (FICI-GP) in primary care. Journal of Interprofessional Care, 26(4), 297-304.
  • Bajorek, B., Masood, N., Krass, I. (2012). Development of a Computerised Antithrombotic Risk Assessment Tool (CARAT) to optimise therapy in older persons with atrial fibrillation. Australasian Journal on Ageing, 31(2), 102-109.
  • Balisa-Rocha, B., Guimaraes, V., Mesquita, A., Aguiar, P., Krass, I., Pereira de Lyra Jr., D. (2012). Enhancing Health Care for Type 2 diabetes in Northern Brazil: A Pilot Study of Pharmaceutical Care in Community Pharmacy. African Journal of Pharmacy and Pharmacology, 6(35), 2584-2591.
  • Bassett-Clarke, D., Krass, I., Bajorek, B. (2012). Ethnic differences of medicines-taking in older adults: a cross cultural study in New Zealand. The International Journal of Pharmacy Practice, 20(2), 90-98.
  • Emmerton, L., Smith, L., LeMay, K., Krass, I., Saini, B., Bosnic-Anticevich, S., Reddel, H., Burton, D., Stewart, K., Armour, C. (2012). Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Services Research, 12(1), 1-10.
  • van Dalem, J., Krass, I., Aslani, P. (2012). Interventions promoting adherence to cardiovascular medicines. International Journal of Clinical Pharmacy, 34(2), 295-311.
  • Eissa, A., Krass, I., Bajorek, B. (2012). Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). Journal Of Clinical Pharmacy And Therapeutics, 37(6), 620-629.
  • Lowres, N., Freedman, S., Redfern, J., McLachlan, A., Krass, I., Bennett, A., Briffa, T., Bauman, A., Neubeck, A. (2012). Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke in an ambulant population aged >65 years (SEARCH-AF stroke prevention study): a cross-sectional study protocol. BMJ Open, 2(3), 1-6.
  • Mansoor, S., Krass, I., Aslani, P. (2012). Strategies used to support patients' adherence to medication: a national survey of community pharmacists. Joint ASCEPT-APSA 2012 Conference: Medication Safety, Australia.

2011

  • Aslani, P., Rose, G., Chen, T., Whitehead, P., Krass, I. (2011). A community pharmacist delivered adherence support service for dyslipidaemia. European Journal of Public Health, 21(5), 567-572.
  • Krass, I., Bell, J. (2011). An International Perspective. In Janet Krska (Eds.), Pharmacy in Public Health, (pp. 67-81). London: Pharmaceutical Press.
  • Saini, B., LeMay, K., Emmerton, L., Krass, I., Smith, L., Bosnic-Anticevich, S., Stewart, K., Burton, D., Armour, C. (2011). Asthma disease management-Australian pharmacists' interventions improve patients' asthma knowledge and this is sustained. Patient Education and Counseling, 83(3), 295-302.
  • Kanjanarach, T., Krass, I., Cumming, R. (2011). Australian community pharmacists' practice in complementary medicines: A structural equation modeling approach. Patient Education and Counseling, 83(3), 352-359.
  • Giam, J., McLachlan, A., Krass, I. (2011). Community pharmacy compounding-impact on professional status. International Journal of Clinical Pharmacy, 33(2), 177-182.
  • Krass, I., Hebing, R., Mitchell, B., Hughes, J., Peterson, G., Song, Y., Stewart, K., Armour, C. (2011). Diabetes management in an Australian primary care population. Journal Of Clinical Pharmacy And Therapeutics, 36(6), 664-672.
  • Krass, I., Mitchell, B., Song, Y., Stewart, K., Peterson, G., Hughes, J., Smith, L., White, L., Armour, C. (2011). Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes. Diabetic Medicine, 28(8), 987-993.
  • Mitchell, B., Armour, C., Lee, M., Song, Y., Stewart, K., Peterson, G., Hughes, J., Smith, L., Krass, I. (2011). Diabetes Medication Assistance Service: The pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia. Patient Education and Counseling, 83(3), 288-294.
  • Watts, G., Sullivan, D., Poplawski, N., van Bockxmeer, F., Hamilton-Craig, I., Clifton, P., O'Brien, R., Bishop, W., George, P., Barter, P., Freeman, L., Krass, I., Trent, R., et al (2011). Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements, 12, 221-263.
  • Van, C., Mitchell, B., Krass, I. (2011). General practitioner-pharmacist interactions in professional pharmacy services. Journal of Interprofessional Care, 25(5), 366-372.
  • Krass, I., Armour, C. (2011). Preventing Disease: Screening in the Pharmacy. In Janet Krska (Eds.), Pharmacy in Public Health, (pp. 221-243). London: Pharmaceutical Press.
  • Saini, B., Krass, I., Smith, L., Bosnic-Anticevich, S., Armour, C. (2011). Role of community pharmacists in asthma - Australian research highlighting pathways for future primary care models. The Australasian Medical Journal, 4(4), 190-200.
  • Fuller, J., Wong, K., Krass, I., Grunstein, R., Saini, B. (2011). Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Patient Education and Counseling, 83(3), 325-335.
  • Aslani, P., Mansoor, S., Krass, I. (2011). The provision of an adherence support service by community pharacists. Australasian Pharmaceutical Science Association (2011), Unkown.
  • Armour, C., LeMay, K., Saini, B., Reddel, H., Bosnic-Anticevich, S., Smith, L., Burton, D., Song, Y., Alles, M., Stewart, K., Krass, I., et al (2011). Using the Community Pharmacy to Identify Patients at Risk of Poor Asthma Control and Factors which Contribute to this Poor Control. Journal of Asthma, 48(9), 914-922.

2010

  • Aslani, P., Rose, G., Chen, T., Whitehead, P., Krass, I. (2010). A community pharmacist delivered adherence support service for dyslipidaemia. European Journal of Public Health, 21(5), 567-572.
  • Hamrosi, K., Aslani, P., Krass, I., Raynor, D. (2010). Consumer medicine information (CMI) with benefits: are they what consumers want?. Australasian Pharmaceutical Science Association Annual Conference (2010). Australasian Pharmaceutical Science Association.
  • Livingston, C., Krass, I., Li, Q. (2010). Factors Predicting the Recommendations of General Practitioners on Herbal Therapies and Dietary Supplements to Patients. Journal of Complementary and Integrative Medicine, 7(1), 1-14.
  • Um, I., Armour, C., Krass, I., Gill, T., Chaar, B. (2010). Managing obesity in pharmacy: the Australian experience. Pharmacy World and Science, , 1-10.
  • Puspitasari, H., Aslani, P., Krass, I. (2010). Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies. International Journal of Pharmacy Practice, 18(4), 202-208.
  • Smith, L., Krass, I., Sainsbury, E., Rose, G. (2010). Pharmacy students' approaches to learning in undergraduate and graduate entry programs. American Journal of Pharmaceutical Education, 74(6), 1-6.
  • Giam, J., McLachlan, A., Krass, I. (2010). Specialized compounding in community pharmacies: Organizational perspective. Journal of the American Pharmacists Association, 50, 354-361.

2009

  • Puspitasari, H., Aslani, P., Krass, I. (2009). A review of counseling practices on prescription medicines in community pharmacies. Research in Social and Administrative Pharmacy, 5(3), 197-210.
  • Aslani, P., Krass, I. (2009). Adherence: a review of education, research, practice and policy in Australia. Pharmacy Practice, 7(1), 1-10.
  • Bajorek, B., Ogle, S., Duguid, M., Shenfield, G., Krass, I. (2009). Balancing risk versus benefit: the elderly patient's perspective on warfarin therapy. Pharmacy Practice, 7(2), 113-123.
  • Ryan, G., Hanrahan, J., Krass, I., Sainsbury, E., Smith, L. (2009). Best Practices Assessment to Guide Curricular Change in a Bachelor of Pharmacy Program. American Journal of Pharmaceutical Education, 73(1), 1-8.
  • VanRoozendaal Bob, B., Krass, I. (2009). Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes. Pharmacy World and Science, 31(5), 580-595.
  • Krass, I., Mitchell, B., Armour, C. (2009). Early experiences in the implementation of the Diabetes Pilot Program Stage 1. Australian Journal of Pharmacy, 90(1070), 69-71.
  • Aslani, P., Krass, I., Bajorek, B., Thistlethwaite, J., Bunker, J., Tofler, G. (2009). Exploring the barriers to achieving quality use of medicines in cardiovascular health. Australasian Pharmaceutical Science Association (APSA) Annual Conference (2009) Aus-CRS Symposium, Mount Waverley, Melbourne, Australia: Australasian Pharmaceutical Science Association.
  • Puspitasari, H., Aslani, P., Krass, I. (2009). How do Australian metropolitan and rural pharmacists counsel consumers with prescriptions? Pharmacy World and Science, 31(3), 394-405.
  • Taylor, S., Hourihan, F., Krass, I., Armour, C. (2009). Measuring consumer preference for models of diabetes care delivered by pharmacists. Pharmacy Practice, 7(4), 195-204.
  • Krass, I., Delaney, C., Glaubitz, S., Kanjanarach, T. (2009). Measuring patient satisfaction with diabetes disease state management services in community pharmacy. Research in Social and Administrative Pharmacy, 5(1), 31-39.
  • Chaar, B., Brien, J., Krass, I. (2009). Professional ethics in pharmacy practice: developing a psychometric measure of moral reasoning. Pharmacy World and Science, 31(4), 439-449.
  • Tran, A., Fuller, J., Wong, K., Krass, I., Grunstein, R., Saini, B. (2009). The development of a sleep disorder screening program in Australian community pharmacies. Pharmacy World and Science, 31(4), 473-480.
  • Ryan, G., Bonanno, H., Krass, I., Scouller, K., Smith, L. (2009). Undergraduate and Postgraduate Pharmacy Students Perceptions of Plagiarism and Academic Honesty. American Journal of Pharmaceutical Education, 73(6), 1-8.

2008

  • Saini, B., Filipovska, J., Bosnic-Anticevich, S., Taylor, S., Krass, I., Armour, C. (2008). An evaluation of a community pharmacy-based rural asthma management service. Australian Journal of Rural Health, 16(2), 100-108.
  • Armour, C., Smith, L., Krass, I. (2008). Community pharmacy, disease state management, and adherence to medication - A review. Disease Management and Health Outcomes, 16(4), 245-254.
  • Puspitasari, H., Aslani, P., Krass, I. (2008). Consumers’ experiences of medicine information in community pharmacies. 15th International Social Pharmacy Workshop.
  • O'Connor, J., Seeto, C., Saini, B., Bosnic-Anticevich, S., Krass, I., Armour, C., Smith, L. (2008). Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Education and Counseling, 70(1), 111-117.
  • Puspitasari, H., Aslani, P., Krass, I. (2008). Provision of prescription medicines information by community pharmacists: A consumer and pharmacist perspective. Biennial Faculties of Health Research Conference: From Cell to Society 6, Australia: Faculty of Health Science, The University of Sydney.
  • Scouller, K., Bonanno, H., Smith, L., Krass, I. (2008). Student experience and tertiary expectations: factors predicting academic literacy amongst first-year pharmacy students. Studies in Higher Education, 33(2), 167-178.

2007

  • Raynor, D., Svarstad, B., Knapp, P., Aslani, P., Rogers, M., Koo, M., Krass, I., Silcock, J. (2007). Consumer medication information in the United States, Europe, and Australia: a comparative evaluation. Journal of the American Pharmacists Association, 47(6), 717-724.
  • Gordois, A., Armour, C., Brillant, M., Bosnic-Anticevich, S., Burton, D., Emmerton, L., Krass, I., Saini, B., Smith, L., Stewart, K. (2007). Cost-effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes, 15(6), 387-396.
  • Aslani, P., Benrimoj, S., Krass, I. (2007). Development and evaluation of a training program to foster the use of written drug information in community pharmacies. Part 2: evaluation. Pharmacy Education, 7(2), 141-149.
  • Koo, M., Krass, I., Aslani, P. (2007). Evaluation of written medicine information: validation of the Consumer Information Rating Form. The Annals of Pharmacotherapy, 41(6), 951-956.
  • Van, C., Krass, I., Mitchell, B. (2007). General practitioner perceptions of extended pharmacy services and modes of collaboration with pharmacists. Journal of Pharmacy Practice and Research, 37(3), 182-186.
  • Bajorek, B., Ogle, S., Duguid, M., Shenfield, G., Krass, I. (2007). Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers. Medical Journal of Australia, 186(4), 175-180.
  • Armour, C., Smith-Brillant, M., Krass, I. (2007). Pharmacists' views on involvement in pharmacy practice research: Strategies for facilitating participation. Pharmacy Practice, 5(2), 59-66.
  • Armour, C., Brillant, M., Krass, I. (2007). Pharmacists' views on involvement in pharmacy practice research: Strategies for facilitating participation. Pharmacy Practice, 5(2), 59-66.
  • Armour, C., Bosnic-Anticevich, S., Smith-Brillant, M., Burton, D., Emmerton, L., Krass, I., Saini, B., Smith, L., Stewart, K. (2007). Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax: an international journal of respiratory medicine, 62(6), 496-502.
  • Smith, L., Saini, B., Krass, I., Chen, T., Bosnic-Anticevich, S., Sainsbury, E. (2007). Pharmacy students' approaches to learning in an Australian university. American Journal of Pharmaceutical Education, 71(6), 120-1-120-8.
  • Lee, D., Armour, C., Krass, I. (2007). The development and evaluation of written medicines information for type 2 diabetes. Health Education Research, 22(6), 918-930.
  • Krass, I., Armour, C., Mitchell, B., Smith-Brillant, M., Dienaar, R., Hughes, J., Lau, P., Peterson, G., Stewart, K., Taylor, S., et al (2007). The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Medicine, 24(6), 677-683.
  • Smith, L., Bosnic-Anticevich, S., Mitchell, B., Saini, B., Krass, I., Armour, C. (2007). Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Social Science and Medicine, 64(7), 1501-1511.

2006

  • Armour, C., Krass, I., Hulme, F., Dalton, A., Saini, B., Filipovska, J., Bosnic-Anticevich, S., Taylor, S. (2006). ABS71: An evaluation of a community pharmacy based rural asthma management service. Primary Care Respiratory Journal, 15(3), 205-205.
  • Burton, D., Simpson, M., Wettenhall, J., Armour, C., Bosnic-Anticevich, S., Saini, B., Krass, I., Smith, L., Smith, L., Smith-Brillant, M., et al (2006). ACCEPTABILITY AND UTILITY OF SPIROMETRY MEASUREMENT IN THE PHARMACY ASTHMA CARE PROGRAM. 2006 Annual Scientific Meetings, The Thoracic Society of Australia and New Zealand & The Australian and New Zealand Society of Respiratory Science, Western Australia: Asian Pacific Society of Respirology.
  • Saini, B., Smith, L., Armour, C., Krass, I. (2006). An educational intervention to train community pharmacists in providing specialized asthma care. American Journal of Pharmaceutical Education, 70(5), Article 118-1-118-10.
  • Armour, C., Bosnic-Anticevich, S., Smith-Brillant, M., Burton, D., Emmerton, L., Gordois, A., Krass, I., Saini, B., Smith, L., Stewart, K. (2006). Asthma service delivered in community pharmacy provides positive clinical and humanistic outcomes and is cost-effective. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Chaar, B., Brien, J., Krass, I. (2006). Developing an instrument for measuring moral reasoning and professional ethics in pharmacy.
  • Lee, D., Armour, C., Krass, I. (2006). Development and evaluation of a diabetes medicines knowledge test (DMKT). 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Aslani, P., Benrimoj, S., Krass, I. (2006). Development and Evaluation of a training program to foster the use of written drug information in community pharmacies - Part 1 - Development. Pharmacy Education, 6(1), 41-52.
  • Saini, B., Smith, L., Armour, C., Krass, I. (2006). Development and evaluation of an educational intervention to facilitate community pharmacists to provide specialised asthma care. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Lee, D., Armour, C., Krass, I. (2006). Development and randomised controlled evaluation of written medicines information (WMI) for type 2 diabetes. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Koo, M., Krass, I., Aslani, P. (2006). Enhancing patient education about medicines: factors influencing reading and seeking of written medicine information. Health expectations : an international journal of public participation in health care and health policy, 9(2), 174-187.
  • Kanjanarach, T., Krass, I., Cumming, R. (2006). Exploratory study of factors influencing practice of pharmacists in Australia and Thailand with respect to dietary supplements and complementary medicines. International Journal of Pharmacy Practice, 14(2), 123-128.
  • Smith, L., Armour, C., Mitchell, B., Saini, B., Krass, I., Bosnic-Anticevich, S. (2006). Pharmacists facilitating patient self-management practices: an Australian community pharmacy asthma self-management programme. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Armour, C., Bosnic-Anticevich, S., Saini, B., Krass, I., Smith, L., Smith-Brillant, M., Burton, D., Simpson, M., Wettenhall, J., Emmerton, L., et al (2006). PHARMACISTS IMPROVING HEALTH CARE FOR ASTHMA. 2006 Annual Scientific Meetings, The Thoracic Society of Australia and New Zealand & The Australian and New Zealand Society of Respiratory Science, Western Australia: Asian Pacific Society of Respirology.
  • Krass, I., Mitchell, B., Clarke, P., Brillant, M., Dienaar, R., Hughes, J., Lau, P., Peterson, G., Stewart, K., Taylor, S., Armour, C., et al (2006). Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Research and Clinical Practice, 75(3), 339-347.
  • Armour, C., Benrimoj, S., Smith-Brillant, M., Gilbert, A., Howarth, H., Krass, I., Lau, P., McNamara, K., Peterson, G., Saini, B. (2006). The community pharmacy research support centre: an Australian consortium developing community pharmacy practice research. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
  • Krass, I., Taylor, S., McInman, A., Armour, C. (2006). The pharmacist's role in continuity of care in type 2 diabetes: An evaluation of a model. Journal of Pharmacy Technology, 22(1), 3-8.
  • Chaar, B., Brien, J., Krass, I. (2006). The role of moral reasoning in the processes of decision making and professional ethics in the Quality Use of Medicines (QUM) and pharmacy. National Medicines Symposium 2006, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2006). Warfarin use in the elderly: the nurses' perspective. Australian Journal of Advanced Nursing, 23(3), 19-25.

2005

  • Taylor, S., Milanova, T., Hourihan, F., Krass, I., Coleman, C., Armour, C. (2005). A cost-effectiveness analysis of a community pharmacist-initiated disease state management service for type 2 diabetes mellitus. International Journal of Pharmacy Practice, 13(1), 33-40.
  • Koo, M., Krass, I., Aslani, P. (2005). Consumer use of Consumer Medicine Information. Journal of Pharmacy Practice and Research, 35(2), 94-98.
  • Krass, I., Taylor, S., Smith, C., Armour, C. (2005). Impact on Medication Use and Adherence of Australian Pharmacists' Diabetes Care Services. Journal of the American Pharmacists Association, 45(1), 33-40.
  • Kritikos, V., Saini, B., Bosnic-Anticevich, S., Krass, I., Shah, S., Taylor, S., Armour, C. (2005). Innovative asthma health promotion by Rural Community Pharmacists: a feasibility study. Health Promotion Journal of Australia, 16(1), 69-73.
  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2005). Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A Pharmacist-Led Multidisciplinary Intervention. Journal of the American Geriatrics Society, 53(11), 1912-1920.
  • Koo, M., Krass, I., Aslani, P. (2005). Patient characteristics influencing evaluation of medicine information: Lessons for patient education. The Annals of Pharmacotherapy, 39(9), 1434-1440.
  • Chaar, B., Brien, J., Krass, I. (2005). Professional ethics in pharmacy: the Australian experience. International Journal of Pharmacy Practice, 13, 195-204.
  • Armour, C., Saini, B., Bosnic-Anticevich, S., Krass, I. (2005). Role of pharmacists in asthma monitoring. In Peter G. Gibson (Eds.), Monitoring Asthma: Lung Biology in Health and Disease Series, Volume 207, (pp. 145-158). United States: Taylor and Francis.
  • Lee, D., Armour, C., Krass, I. (2005). The development and evaluation of written medicine information (WMI) for patients with type 2 diabetes. Australian Journal of Pharmacy, 86(1024), 524-528.
  • Bennett, A., Krass, I., Brien, J. (2005). The future burden of cardiovascular disease: what can pharmacists do? Australian Journal of Pharmacy, 86(1020), 166-169.
  • Kritikos, V., Krass, I., Chan, H., Bosnic-Anticevich, S. (2005). The Validity and Reliability of Two Asthma Knowledge Questionnaires. Journal of Asthma, 42(9), 795-801.

2004

  • Aslani, P., Rose, G., Owen, L., Krass, I., Chen, T., Whitehead, P. (2004). A Therapeutics Outcome Monitoring Service For Hyperlipidaemia. Australian Journal of Pharmacy, 85(1016), 870-873.
  • Saini, B., Krass, I., Armour, C. (2004). Development, Implementation And Evaluation Of A Community Pharmacy-Based Asthma Care Model. The Annals of Pharmacotherapy, 38(11), 1954-1960.
  • Saini, B., Krass, I., Armour, C. (2004). Development, Implementation, and Evaluation of a Community Pharmacy-Based Asthma Care Model. The Annals of Pharmacotherapy, 38(11), 1954-1960.
  • Armour, C., Taylor, S., Hourihan, F., Smith, C., Krass, I. (2004). Implementation And Evaluation Of Australian Pharmacists' Diabetes Care Services. Journal of the American Pharmacists Association, 44(4), 455-466.

2003

  • Bajorek, B., Ogle, S., Krass, I., Duguid, M., Shenfield, G. (2003). Atrial Fibrillation in the Elderly: Management Issues. Indian Journal of Gerontology, 17(3 & 4), 244-272.
  • Koo, M., Krass, I., Aslani, P. (2003). Factors influencing consumer use of written drug information. The Annals of Pharmacotherapy, 37(2), 259-267.
  • Krass, I., Hourihan, F., Chen, T. (2003). Health promotion and screening for cardiovascular risk factors in NSW: a community pharmacy model. Health Promotion Journal of Australia, 14(2), 101-107.
  • Rossing, C., Holme Hansen, E., Krass, I., Traulsen, J. (2003). Pharmaceutical care in denmark: perceived importance of medicine-related problems and participation in postgraduate training. Pharmacy World and Science, 25(2), 73-78.
  • Kritikos, V., Watt, H., Krass, I., Sainsbury, E., Bosnic-Anticevich, S. (2003). Pharmacy students' perceptions of their profession relative to other health care professions. International Journal of Pharmacy Practice, 11(2), 121-129.
  • Chaar, B., Brien, J., Krass, I. (2003). Professional ethics in pharmacy. Australian Journal of Pharmacy, 84, 856-859.
  • Hourihan, F., Krass, I., Chen, T. (2003). Rural Community Pharmacy: A Feasible Site for a Health Promotion and Screening Service for Cardiovascular Risk Factors. Australian Journal of Rural Health, 11(1), 28-35.
  • Rossing, C., Hansen, E., Krass, I. (2003). The provision of pharmaceutical care in Denmark: a cross-sectional survey. Journal Of Clinical Pharmacy And Therapeutics, 28(4), 311-318.

2002

  • Krass, I., Bajorek, B. (2002). "The pill" is now into its third generation. Retail Pharmacy, , 28-29.
  • Aslani, P., Bosnic-Anticevich, S., Sainsbury, E., Koo, M., Roberts, A., Krass, I. (2002). A report of the Teachers' workshop held in Sydney, Australia, 2002. Pharmacy Education, , 213-219.
  • Krass, I., Bajorek, B. (2002). An update on osteoporosis. Retail Pharmacy, , 35-36.
  • Rossing, C., Hansen, E., Krass, I. (2002). Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. Journal of Social and Administrative Pharmacy, 19(2), 55-64.
  • Krass, I. (2002). Change in pharmacy toward patient care or business. Journal of Social and Administrative Pharmacy, , 202-202.
  • Krass, I., Bajorek, B. (2002). Cholesterol and coronary heart disease. Retail Pharmacy, , 20-20.
  • Bosnic-Anticevich, S., Krass, I., Saini, B., Armour, C., Shah, S. (2002). Comparison of two methods of training of undergraduate students in asthma, knowledge, confidence and skills.
  • Koo, M., Krass, I., Aslani, P. (2002). Consumer medicines information: What do consumers do with them?. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Koo, M., Krass, I., Aslani, P. (2002). Consumer opinions on medicines information and factors affecting its use - an Australian experience. International Journal of Pharmacy Practice, 10, 107-114.
  • Koo, M., Krass, I., Aslani, P. (2002). Development of a tool to measure factors affecting the use of written information by consumers. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Saini, B., Jogia, R., Krass, I., Armour, C. (2002). Evaluation of a practice-based research design using an asthma care model. International Journal of Pharmacy Practice, 10, 177-184.
  • Krass, I., Bajorek, B. (2002). Gout comes under attack. Retail Pharmacy, , 28-29.
  • Krass, I., Bajorek, B. (2002). Have trouble explaining INR to warfarin patients. Retail Pharmacy, , 29-30.
  • Krass, I. (2002). Hyperlipidaemia. Australian Pharmacist, , 190-194.
  • Masood, N., Armour, C., Krass, I. (2002). Identifying potential medication related interventions in type 2 diabetes: a mechanism for enhanced community pharmacy services. Journal of Social and Administrative Pharmacy, 19(5), 170-179.
  • Saini, B., Krass, I., Armour, C. (2002). Improvement in asthma management through a specialty pharmacy asthma care model. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Krass, I., Taylor, S., Armour, C., Stephenson,, S., Thusi, I., Hourihan, F. (2002). Increasing adherence to dedications through delivery of a disease state management service for Type 2 diabetes in community pharmacies. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Krass, I., Bajorek, B. (2002). Paying attention to AD/HD. Retail Pharmacy, , 24-25.
  • Armour, C., Taylor, S., Smith, C., Krass, I., Hourihan, F. (2002). Pharmacists improve clinical outcomes for diabetes using a disease state management approach. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
  • Bosnic-Anticevich, S., Saini, B., Krass, I., Armour, C. (2002). Pharmacy action plan program - pharmacists addressing issues in the community. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
  • Smith, L., Krass, I. (2002). Responding to changes in pharmacy practice. Synergy, , 9-10.
  • Krass, I., Bajorek, B. (2002). Seize the knowledge on new anticonvulsants. Retail Pharmacy, , 28-29.
  • Krass, I., Aslani, P. (2002). The 12th International Social Pharmacy Workshop. Australia: Faculty of Pharmacy, University of Sydney.
  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2002). The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation. Australasian Journal on Ageing, 21(1), 36-41.
  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2002). The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation. Australasian Journal on Ageing, 21(1), 36-41.
  • Krass, I., Bajorek, B. (2002). To be or not to be ulcer-free? that is the NSAID question. Retail Pharmacy, , 19-20.
  • Krass, I., Svarstad, B., Bultman, D. (2002). Using alternative methodologies for evaluating patient medication leaflets. Patient Education and Counseling, 47(1), 29-35.
  • Bajorek, B., Krass, I. (2002). Warfarin use in elderly patients with atrial fibrillation: the pharmacy perspective. Australasian Pharmaceutical Scinece Association Conference, Sydney: Faculty of Pharmacy, University of Sydney.
  • Krass, I., Bajorek, B. (2002). What was new in medicines for 2002. Retail Pharmacy, , 35-36.

2001

  • Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2001). A survey of long-term antiarrhythmic therapy in elderly patients with atrial fibrillation. Australian Journal of Hospital Pharmacy, 31(2), 93-97.
  • Chen, T., Crampton, M., Krass, I., Benrimoj, S. (2001). Collaboration between community pharmacists and GPs - impact on interprofessional communication. Journal of Social and Administrative Pharmacy, 18(3), 83-90.
  • Hourihan, F., Krass, I., Chen, T., Coper,, L. (2001). Consumer evaluation of a pharmacy based health promotion and screening service in rural NSW.
  • Teh, R., Chen, T., Krass, I. (2001). Consumer perspectives of pharmacist-delivered health information and screening services. International Journal of Pharmacy Practice, 9, 261-267.
  • Smith, L., Krass, I. (2001). Responding to changes in Pharmacy practice: A collaboration between Nursing and Pharmacy in developing social Pharmacy curriculum. College of Health Sciences Ed-Health 2001, uk: World Scientific Publishing.
  • Saini, B., Krass, I., Armour, C. (2001). Specialisation in asthma: current practice and future roles - a qualitative study of practising community pharmacists. Journal of Social and Administrative Pharmacy, 18(5), 169-177.

2000

  • Jones, J., Krass, I., Holder, G., Robinson, R. (2000). Selecting Pharmacy students with appropriate communication skills. American Journal of Pharmaceutical Education, 64, 68-73.

1999

  • Holder, G., Jones, J., Robinson, R., Krass, I. (1999). Academic Literacy Skills and Progression Rates amongst Pharmacy Students. Higher Education Research and Development, 18(1), 19-30.
Back to Top

Keywords

Asthma; Health services and management; Sleep disorders; Cardiovascular diseases; Ageing

Back to Top

For support on your academic profile contact Research Support.